Acute coronary syndrome (ACS) represents a leading cause of mortality and morbidity worldwide. Antiplatelet therapy is a cornerstone of ACS management.
- The current available antiplatelet therapies for patients with ACS
- The challenges in antiplatelet therapy selection
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
This content has been developed independently of the sponsor, AstraZeneca, which has had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.